Screening the receptorome: an efficient approach for drug discovery and target validation
- 15 July 2006
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 11 (15-16), 708-716
- https://doi.org/10.1016/j.drudis.2006.06.012
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Playing dirtyNature, 2005
- SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonistBioorganic & Medicinal Chemistry Letters, 2005
- Mining the ReceptoromePublished by Elsevier BV ,2005
- Development of KiBank, a database supporting structure-based drug designComputational Biology and Chemistry, 2004
- Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor SubtypesJournal of Pharmacology and Experimental Therapeutics, 2002
- A Homogeneous High Throughput Nonradioactive Method for Measurement of Functional Activity of Gs-Coupled Receptors in MembranesSLAS Discovery, 2002
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian CellsBasic & Clinical Pharmacology & Toxicology, 1995
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995